Back to top
more

NEXTGEN HEALTHCARE, INC (NXGN)

(Delayed Data from NSDQ)

$19.75 USD

19.75
265,337

+0.51 (2.65%)

Updated May 3, 2019 04:00 PM ET

After-Market: $19.76 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Surmodics' Pounce Thrombus Retrieval System Gets FDA Nod

The FDA clearance of Surmodics' (SRDX) Pounce Thrombus Retrieval System will bolster the current treatment of complex PAD.

NXGN or TRHC: Which Is the Better Value Stock Right Now?

NXGN vs. TRHC: Which Stock Is the Better Value Option?

Sriparna Ghosal headshot

3 Great MedTech Stocks to Pick Amid the Coronavirus Crisis

Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.

Here's Why You Should Add NextGen Stock to Your Portfolio Now

Investor optimism is high on NextGen (NXGN) stock, thanks to solid prospects.

Schrodinger (SDGR) Jumps: Stock Rises 8.5%

Schrodinger (SDGR) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Tirthankar Chakraborty headshot

Fed to Hold Rates Near Zero Until End of 2023: 5 Big Winners

The Fed sees rates near zero until the economy reaches full employment and inflation runs "moderately" above its 2% goal. But these aren't happening soon and investors can get used to low rates.

The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.

Debanjana Dey headshot

Buy 4 Beaten-Down MedTech Value Stocks Amid September Selloffs

Here are some dirt-cheap MedTech value stocks which have been battered by the pandemic-led market meltdown and can be considered for long-term gains.

Urmimala Biswas headshot

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

Postponement of elective surgeries leading to lower product bookings cloud Zacks-Medical Info Systems industry prospects. However, coronavirus-led demand for contactless services should aid the space. TXG, MDRX, NXGN should be the forerunners.

The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS

The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS

NXGN vs. TRHC: Which Stock Is the Better Value Option?

NXGN vs. TRHC: Which Stock Is the Better Value Option?

Debanjana Dey headshot

4 MedTech Growth Stocks With Strong ROE to Buy Amid Coronavirus

Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

NextGen Healthcare Introduces New Behavioral Health Suite

NextGen Healthcare's (NXGN) new behavioral health suite aims to provide whole person care with support services for healthcare providers and clinicians.

Strength Seen in Fulgent Genetics (FLGT): Stock Soars 11.6%

Fulgent Genetics (FLGT) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.

OPKO Health's BioReference Laboratories Introduces NGS Assay

OPKO Health's (OPK) OnkoSight Advanced is a NGS assay that facilitates revolutionary DNA mutational profiling of tumor samples.

Why Is Nextgen Healthcare (NXGN) Up 5.6% Since Last Earnings Report?

Nextgen Healthcare (NXGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NXGN vs. TRHC: Which Stock Should Value Investors Buy Now?

NXGN vs. TRHC: Which Stock Is the Better Value Option?

Here's Why You Should Add NextGen Stock to Your Portfolio Now

Investor optimism is high on NextGen (NXGN) stock, thanks to solid prospects.

NXGN or HMSY: Which Is the Better Value Stock Right Now?

NXGN vs. HMSY: Which Stock Is the Better Value Option?

NextGen Healthcare (NXGN) Tops Q1 Earnings & Revenue Estimates

NextGen (NXGN) benefited from its Recurring segment in Q1.

Nextgen Healthcare (NXGN) Q1 Earnings and Revenues Top Estimates

Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 133.33% and 13.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Nextgen Healthcare (NXGN) to Report a Decline in Earnings: What to Look Out for

Nextgen Healthcare (NXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Nextgen Healthcare (NXGN) to Report a Decline in Earnings: What to Look Out for

Nextgen Healthcare (NXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nextgen Healthcare (NXGN) Up 4.8% Since Last Earnings Report: Can It Continue?

Nextgen Healthcare (NXGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.